High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype

  1. Montoyo-Pujol, Y.G.
  2. Ponce, J.J.
  3. Delgado-García, S.
  4. Martín, T.A.
  5. Ballester, H.
  6. Castellón-Molla, E.
  7. Ramos-Montoya, A.
  8. Lozano-Cubo, I.
  9. Sempere-Ortells, J.M.
  10. Peiró, G.
Zeitschrift:
Cancer Cell International

ISSN: 1475-2867

Datum der Publikation: 2024

Ausgabe: 24

Nummer: 1

Art: Artikel

DOI: 10.1186/S12935-024-03554-4 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus